GENE ONLINE|News &
Opinion
Blog

acquisition
Ajinomoto to Acquire Forge Biologics for $620 Million to Boost Gene Therapy Capabilities
2023-11-14
Strides Pharma to Sell Manufacturing Facility in Cost Optimization Move
2023-10-31
Novo Nordisk Acquires Ocedurenone with $1.3B for Hypertension and Cardiovascular Disease
2023-10-18
Kyowa Kirin to Acquire Orchard Therapeutics, Forging a Path in Genetic Medicine
2023-10-11
Danaher Acquires Abcam for $5.7 Billion
2023-08-31
Novo Nordisk Delivers Strong H1 Financial Performance, With Acquisition to Expand Weight Loss Market
2023-08-16
Novartis Acquires DTx Pharma and Expands Its Neuroscience Pipeline
2023-07-20
GeneOnline’s Weekly News Highlights: July 10-14
2023-07-17
Astellas Trains Sights On Iveric Bio In $5.9 Billion Acquisition
2023-05-03
Pfizer Acquires Seagen for $43 Billion to Capture Leading Position in Oncology
2023-03-14
Prenetics Announces Acquisition of ACT Genomics, Aiming for the Multi-billion Market of Precision Oncology
2022-12-21
European Commission Continues Fight with Illumina and Orders Grail Acquisition Divestment
2022-12-07
Johnson & Johnson Throws Down $16.6 billion for Abiomed
2022-11-01
Thermo Fisher Announces the Multi-Billion Dollar Acquisition of The Binding Site Group
2022-10-31
Eli Lilly Snatches Up Akouos Treating Ear Conditions for $487 million
2022-10-18
1 2
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top